Amal Therapeutics SA Switzerland
Research
Date range: 1 April 2021 - 31 March 2022
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Amal Therapeutics SA published between 1 April 2021 - 31 March 2022 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
2 | 0.13 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 2 | 0.13 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
0.00 | 0.04 | 0.00 | 0.00 | 0.00 |
Collaboration
Date range: 1 April 2021 - 31 March 2022
International vs. domestic collaboration by Share
- 0.00% Domestic
- 100.00% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Amal Therapeutics SA by Share (0 total)
Top 10 international collaborators with Amal Therapeutics SA by Share (8 total)
-
Amal Therapeutics SA and University of Oxford
(0.86)
-
Amal Therapeutics SA and C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim)
(0.58)
-
Amal Therapeutics SA and Medical University of Innsbruck (MUI)
(0.50)
-
Amal Therapeutics SA and Christian Doppler Laboratory for Viral Immunotherapy of Cancer
(0.28)
-
Amal Therapeutics SA and University of Veterinary Medicine Vienna (VUM)
(0.19)
-
Amal Therapeutics SA and Medical University of Vienna (MUW)
(0.13)
-
Amal Therapeutics SA and Oxford University Hospitals NHS Trust (OUH)
(0.07)
-
Amal Therapeutics SA and Ludwig Maximilians University of Munich (LMU)
(0.07)

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.